New York · 2025 Regular Session · Bill
S 10260: Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 10260 is a bill introduced in the New York Senate on May 8, 2026. According to its official title, it concerns: Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state. Primary sponsor: Lea Webb (Democratic/Working Families). It lists 2 additional sponsors. Most recent recorded action (May 8, 2026): REFERRED TO HEALTH.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state; requires tests be made available within twelve months.
Sponsors
Sponsors by party (alphabetical): Democratic 1 · Democratic/Working Families 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Lea Webb | Primary sponsor | Democratic/Working Families | Senate | 52 |
| Kevin Parker | Co-sponsor | Democratic/Working Families | Senate | 21 |
| Chris Ryan | Co-sponsor | Democratic | Senate | 50 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HEALTH